Proposed Nasdaq symbol TALS. Business: Phase 3 biotech developing allongeneic cell therapies for organ transplant recipients. Waterdrop - Beijing, ...
News
- Initial public offerings scheduled to debut next week
- Calithera: Q1 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $20.4 million in its first quarter.
- Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share. The biotechnology company posted ...
- WTO chief: Vaccine waiver helpful, not key for virus fight
For instance, Germany, a research powerhouse with strong biotech and pharmaceutical sectors, spoke out against waiving the protections. “The main ...
- 5 most popular innovation stories in Houston this week
This week's roundup of Houston innovators includes Daniel Powell of Spark Biomedical, Carrie Colbert of Curate Capital, and Carson Hager of SafeFun. ... their counterparts in Dallas-Fort Worth, San Antonio, and Austin for overuse ...